Most notably, polymorphisms in or around TERT (encoding telomerase reverse transcriptase) are strongly associated with various cancers, including breast, bladder and prostate cancers and melanoma (Rafnar et al. 2009; Bojesen et al. 2013). This evidence concerns the gene TERT and prostate carcinoma.